Keisuke Yonehara receives grant from the Novo Nordisk Foundation

Group Leader Keisuke Yonehara has been awarded a 2 year project grant of 1.2 mio. DKK from the Novo Nordisk Foundation, Medical and Natural Sciences Research, to support his research on function and dysfunction of optokinetic circuits in mice.

2015.12.08 | Karen Bech

Find further information about the grant at the Novo Nordisk Foundation website
















Awards, KeisukeYonehara